Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174792 | SCV000226160 | uncertain significance | not provided | 2017-06-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764901 | SCV000896061 | uncertain significance | Congenital central hypoventilation; Hirschsprung disease, susceptibility to, 1; Multiple endocrine neoplasia type 2B; Pheochromocytoma; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia type 2A | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001437744 | SCV001640607 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255313 | SCV002529980 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-21 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002255313 | SCV002732206 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |